Biotech Values

[iwfal]

RVNC

Revance plans to report topline results for the ASPEN-1 cervical dystonia and Phase 2 plantar fasciitis trials in 2H of 2020 [as per prior guidance], and will provide additional updates as there is greater clarity.
...
The upper facial lines trial is fully enrolled, and all subjects have been dosed. Revance is on-track for 2Q 2020 readouts of the forehead and crow’s feet line Phase 2 studies

This seems odd to me. Eg How can you accurately assess facial lines without a really good set of pictures (well lit etc) comparable to the set initially taken.

And for cervical dystopia, patients can have twitches, which I assume are part of the critieria. But those wld be particularly hard to assess over video since much of the telecon SW is low frame rate.

All told I’d think tele-assessment wld add significant noise to the data, thus making it much more difficult to get positive results?